Citrus Bergamot

The VerdictMODERATE CONVICTION

Bergamot really lowers cholesterol, but only the fruit extract, not the aromatherapy oil, and the effect is modest.

If you want the cholesterol effect, buy a standardized oral polyphenol extract, not the aromatherapy oil and not the juice. Then recheck your lipid panel in 12 weeks to confirm you actually respond.

Bergamot is a citrus fruit, and its flavonoids nudge your liver to make less cholesterol and your gut to absorb less of it. It is marketed as a "natural statin" because two of its compounds are shaped a bit like statin drugs, but it does not block the cholesterol enzyme the way a real statin does. It works around the pathway rather than slamming the door on it, which is why the effect is real but gentler.

That's the general answer. Your stack is different.

Check your whole stack

Bergamot is a Mediterranean citrus fruit grown in Calabria, southern Italy. The same name covers two different products: an oral polyphenol extract of the fruit, taken in capsules for cholesterol, and the essential oil pressed from the peel (the thing that flavors Earl Grey tea), used in aromatherapy for stress and sleep. Only the oral extract is the cholesterol product.

If you want the cholesterol effect, buy a standardized oral polyphenol extract, not the aromatherapy oil and not the juice.

The two products share a name and almost nothing else. Then recheck your lipid panel in about 12 weeks, because responders and non-responders both exist.

Decision takes 2 minutes at the shelf.

The Protocol

Who	Dose	Timing	Form	Loading
High cholesterol (general)	400-1500mg/day (one to two capsules)	With meals	Standardized polyphenol extract	No
Metabolic syndrome / weight	Up to 600mg/day favored; up to 1300mg dose-dependent	With meals	Flavonoid / pectin-enriched extract	No
Statin adjunct (supervised)	1000mg/day BPF + low-dose statin	With meals	Standardized polyphenolic fraction	No
Stress / sleep	Inhaled drops (not standardized)	Inhalation	Essential oil — NOT for cholesterol	No

Standardized extract

BPF / Bergavit / Brumex

The form with the actual trial evidence. Start here.

Phytosome

Enhanced absorption

For poor responders to a standard extract.

Juice

Polyphenols absorb poorly

Why concentrated extracts exist.

Essential oil

Phototoxic furocoumarins

Aromatherapy only. Not the lipid product.

Absorption tip: take the oral extract with food. The phytosome forms were built specifically because raw bergamot polyphenols absorb poorly, so if you respond weakly to a standard extract, a phytosome is the evidence-based next step.

Safety & Interactions

Grapefruit-type drug interaction (CYP3A4)

Bergamot's furocoumarins can act like grapefruit juice and raise blood levels of some drugs, including statins, calcium-channel blood-pressure drugs, and certain immunosuppressants. Tell your prescriber before starting.

Additive with statins

Bergamot and statins both lower LDL, which trials used deliberately as a dose-sparing strategy. That also means stacking two lipid agents, which should be supervised, not improvised.

Skin photosensitivity (essential oil only)

The peel essential oil contains bergapten, a phototoxic compound. Keep applied skin out of the sun. This does not apply to the oral cholesterol extract.

Who should avoid it

Pregnancy and lactation — no adequate human safety data.
Children — not studied.
Anyone with established heart disease on a prescribed statin — do not self-substitute.

Upper limit: none established. Oral extracts were generally well tolerated in trials lasting 30 days to 6 months. Long-term (multi-year) safety data are incomplete.

MODERATE

The lipid effect is consistent in direction across more than a dozen trials, with a plausible mechanism. It is held back by limited study quality, wildly different products, the dominance of one research group, and the fact that no trial has ever measured a heart attack or stroke.

What would change this verdict?

An independent (non-product-developer), double-blind, placebo-controlled trial of 300+ adults with high LDL, using a third-party-tested standardized extract at a fixed disclosed dose for 24+ weeks, showing a 15%+ placebo-adjusted LDL drop reproduced outside the original Italian research network, would push the lipid claim toward HIGH. A trial powered for actual cardiovascular events over 2+ years is the bigger missing piece, and it does not exist.

Worth Your Money?

Weekly costAbout £2.50–£8 per week at an evidence-based dose (a standardized extract runs roughly £10–£35 a month).

Worth it ifYou have mild-to-moderate high cholesterol or metabolic syndrome, can't tolerate a statin, and buy a standardized extract you can verify with a repeat lipid panel.

Lower priority ifYour fiber intake, diet, and exercise basics aren't dialed in yet. Those move cholesterol more reliably than a supplement, so your first money is better spent there.

Conditional Value

Go Deeper

Want to stop wasting money on supplements that don't work? The Verdict reviews one every week, with the evidence laid out plainly. Free.

Join The Verdict — free

Claims vs Evidence — See What the Research Found

What People Claim

Bergamot is marketed as a "natural statin": a Mediterranean citrus whose flavonoids lower LDL cholesterol and triglycerides without the muscle pain of prescription statins. Sellers point to two compounds, brutieridin and melitidin, that are shaped like statin molecules, and to a real and growing base of human trials, some showing reductions approaching 40 percent. It is pitched as the answer for people who can't tolerate statins, or who want a food-based way to manage cholesterol.

Separately, and confusingly under the same name, bergamot essential oil is sold for stress, anxiety, and sleep through aromatherapy. Consumers routinely treat these as the same thing. The broader marketing also folds in weight loss, fatty-liver improvement, blood-sugar control, and general antioxidant anti-aging benefits.

What the Evidence Actually Shows

Claim	Evidence	Verdict
Lowers LDL / cholesterol / triglycerides (high lipids)	LDL down 7.6–40.8% across 12 trials, dose-dependent MODERATE	Works (oral extract)
Improves glucose / metabolic syndrome	Fasting glucose and insulin resistance down in trials MODERATE	Works
Reduces liver fat (fatty liver)	Real signal, but combination product (bergamot + cardoon) LOW-MOD	Confounded
Weight loss / body composition	Modest in newest meta-analysis, but high variability; big effect is a fiber formula LOW-MOD	Modest, direction only
Reduces anxiety / improves sleep (essential oil)	Mixed; null for PMS; combination blends, unblindable LOW	Weak
Prevents heart attacks / strokes	No outcome trial exists UNTESTED	Unproven

Every trial measured blood markers. None measured an actual cardiovascular event. Treat bergamot as a lipid nudge, not proven heart protection.

The Full Picture — Mechanism, Debate & Nuance

How It Works

Bergamot fruit is unusually rich in flavonoids, plus two distinctive compounds, brutieridin and melitidin, whose shape resembles the statin-binding motif. That resemblance is where the "natural statin" story comes from, and it is mostly story. When researchers tested bergamot extract directly on the cholesterol-making enzyme in liver and gut cells, it did not block the enzyme the way a statin does.

What it appears to do instead is three indirect things: it flips on AMPK (a master metabolic switch that dials down fat and cholesterol production), it lowers how much of the cholesterol-making enzyme the cell produces, and it reduces how much cholesterol your gut absorbs. The effect is real and plausible, but it works around the cholesterol pathway rather than blocking it head-on. These mechanism findings come from cell-culture models, which support the idea but don't by themselves prove the clinical effect.

The Debate

One review (12 trials): LDL down up to 40.8%, "promising alternative."

Another review: small samples, low quality, "cannot be definitively drawn."

One review counts the direction of effect across messy trials; the other weights study quality and publication bias. Both are right: consistent direction, weak rigor.

One trial: weight down nearly 15%.

Most trials: bergamot flavonoids "fail to induce significant weight loss."

The big weight loss came from a pectin/fiber-enriched product. The fiber drove the number, not the bergamot flavonoids.

Headline: ~40% LDL drop (one group's open-label trials of its own extract).

Blinded independent trials: real but more modest reductions.

The biggest effects concentrate in one Calabrian research group using proprietary extracts. Open-label developer trials read as ceilings, not expectations.

Honest Limitations

The product is not one thing

Trials use specific standardized extracts. A generic "bergamot 500mg" capsule may match no tested product, and juice-grade polyphenols absorb poorly. Buying "bergamot" is not buying the trial.

One group, its own products

A large share of the strongest effects come from one research group's proprietary formulations, often open-label. Independent, blinded products move lipids less.

Surrogate markers only

Every trial measures lipids, glucose, or liver fat. Nobody has shown bergamot prevents a heart attack. It is a reasonable LDL nudge, not proven cardiovascular protection.

The Nuance

What doesn't work

"It's a natural statin." Statin-like by shape, not by mechanism. It doesn't directly block the cholesterol enzyme.
"It prevents heart attacks." Untested. Every trial measured blood markers, never an event.
"The essential oil lowers cholesterol." The peel oil is for aromatherapy and is phototoxic. Wrong product.
"Expect a 40% LDL drop." That number is one group's open-label result with its own extract. Independent products do less.

Who benefits most: adults with mild-to-moderate dyslipidemia, statin-intolerant adults seeking a supervised adjunct, and people with metabolic-syndrome features. Food-first note: there is no whole-food equivalent that delivers the concentrated polyphenols, because bergamot juice itself absorbs poorly. But soluble fiber, a better diet, and exercise move cholesterol more reliably and should come first.

Sources

Rondanelli M, et al. (2020). Effect of bergamot on lipid profile in humans: a systematic review. Crit Rev Food Sci Nutr. 12 trials. LDL-C -7.6% to -40.8%, dose-dependent.
Pujia C, et al. (2026). Effect of Citrus bergamia on body composition: SR & meta-analysis of RCTs. Obesity Reviews. 11 RCTs. Weight SMD -0.64 (high heterogeneity).
Mollace V, et al. (2019). Hypoglycemic and hypolipemic effects of a lecithin formulation of bergamot polyphenolic fraction. Endocr Metab Immune Disord Drug Targets. RCT N=60, T2D.
Spanò M, et al. (2023). Effect of Citrus bergamia extract (Brumex) on lipid profile. Phytotherapy Research. RCT double-blind N=50.
Gliozzi M, et al. (2013). Bergamot polyphenolic fraction enhances rosuvastatin effect on LDL-C. Int J Cardiol. Open-label N=77.
Mollace V, et al. (2011). Hypolipemic and hypoglycaemic activity of bergamot polyphenols. Fitoterapia. Human N=237. Foundational.
Musolino V, et al. (2020). Bergamot + wild cardoon reduce liver steatosis. Frontiers in Endocrinology. RCT N=102, fatty liver.
Janda E, et al. (2021). Cholesterol-lowering mechanism of bergamot extract in HepG2/Caco-2 cells. Nutrients. No direct enzyme inhibition; AMPK pathway.
Mollace V, et al. (2017). Clinical pharmacology of Citrus bergamia: a systematic review. Phytotherapy Research. 10 trials, low quality noted.
Bonfili L, et al. (2022). Pharmacological properties of bergapten. Oxid Med Cell Longev. Phototoxic furocoumarin.